Product Information
ENBREL 50 MG/ML SURECLICK is a brand product labeled by Immunex Corporation, priced at $2083.4784 per ML under NDC 58406003204. Its NADAC has been published 363 times since Oct 23, 2019.
Strength
50 mg/mL
Manufacturer
Immunex CorporationNDC
58406003204
Classification
Brand
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ETANERCEPTApproval Type
Biologic (BLA)
FDA Application
BLA103795On Market Since
6/7/2019
Pharmacological Classes
Price Statistics
The NADAC for ENBREL 50 MG/ML SURECLICK has been published 363 times since Oct 23, 2019, and over the history we have for it it has risen 65.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2083.4784 per ML |
|---|---|
| All-time high | $2083.6232 (Sep 16, 2026) |
| All-time low | $1259.1239 (Oct 23, 2019) |
| 52-week high | $2083.6232 |
| 52-week low | $1984.0630 |
| Median price | $1718.0014 |
| Average price | $1681.5196 |
| Largest weekly change | +7.4% (Jan 11, 2023) |
| Weeks tracked | 363 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Immunex Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
etanercept market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tumor Necrosis Factor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENBREL 50 MG/ML SURECLICK?
The current National Average Drug Acquisition Cost (NADAC) for ENBREL 50 MG/ML SURECLICK, manufactured by Immunex Corporation, is $2083.4784 per ML (NDC 58406003204), effective Sep 30, 2026.
How has the price of ENBREL 50 MG/ML SURECLICK changed over time?
Over the history we have for it, the NADAC for ENBREL 50 MG/ML SURECLICK has risen 65.5%. It has been tracked across 363 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for ENBREL 50 MG/ML SURECLICK?
Since Oct 23, 2019, the NADAC for ENBREL 50 MG/ML SURECLICK has ranged from a low of $1259.1239 (Oct 23, 2019) to a high of $2083.6232 (Sep 16, 2026), with a median of $1718.0014 per ML.
Are there cheaper alternatives to ENBREL 50 MG/ML SURECLICK?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENBREL 50 MG/ML SYRINGE, is $2080.5922 per ML — about 0% below ENBREL 50 MG/ML SURECLICK.
Who manufactures ENBREL 50 MG/ML SURECLICK?
ENBREL 50 MG/ML SURECLICK (NDC 58406003204) is labeled by Immunex Corporation, and CMS classifies it as a brand product.